158
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Patient and economic burdens of postherpetic neuralgia in China

, , , , , , , , , , , & show all
Pages 539-550 | Published online: 03 Sep 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Christa Lee, Ning Jiang, Haiwen Tang, Chiyu Ye, Yanfei Yuan & Desmond Curran. (2021) Potential public health impact of the adjuvanted recombinant zoster vaccine among people aged 50 years and older in Beijing. Human Vaccines & Immunotherapeutics 17:10, pages 3735-3746.
Read now

Articles from other publishers (13)

Christa Lee, Nikolaos Giannelos, Desmond Curran, Hengjin Dong, Haiwen Tang, Ning Jiang, Chiyu Ye, Yanfei Yuan & Cheryl Ng. (2023) Lifetime risk of herpes zoster in the population of Beijing, China. Public Health in Practice 5, pages 100356.
Crossref
Minghuan Jiang, Xuelin Yao, Jin Peng, Liuxin Feng, Yue Ma, Xinke Shi, Yu Fang & Hai Fang. (2023) Cost-effectiveness of recombinant zoster vaccine for adults aged ≥50 years in China. American Journal of Preventive Medicine.
Crossref
Gang Han, Yun Han, Lingyan Yu, Yuhua Zhao & Zhenwei Yu. (2023) Patterns and Trends in Pharmacological Treatment for Outpatients with Postherpetic Neuralgia in Six Major Areas of China, 2015–2019. Healthcare 11:5, pages 764.
Crossref
Jeongsoo Kim, Hyeon Cheun, Jeong Jeong & Ho-Jin Lee. (2023) Bibliometric analysis of research articles on post-herpetic neuralgia published from 1991 to 2020. Medicine 102:6, pages e32967.
Crossref
Yuting Chen, Qingqing Wu, Zhengsheng Jin, Yanlan Qin, Fancui Meng & Guilong Zhao. (2022) Review of Voltage-gated Calcium Channel α2δ Subunit Ligands for the Treatment of Chronic Neuropathic Pain and Insight into Structure-activity Relationship (SAR) by Pharmacophore Modeling. Current Medicinal Chemistry 29:30, pages 5097-5112.
Crossref
Zhiqiang Zhang, Zhangtian Xia, Ge Luo & Ming Yao. (2022) Analysis of Efficacy and Factors Associated with Reccurence After Radiofrequency Thermocoagulation in Patients with Postherpetic Neuralgia: a Long-Term Retrospective and Clinical Follow-Up Study. Pain and Therapy 11:3, pages 971-985.
Crossref
Aimin Wang, Kim Rand, Zhihao Yang, Richard Brooks & Jan Busschbach. (2021) The remarkably frequent use of EQ-5D in non-economic research. The European Journal of Health Economics 23:6, pages 1007-1014.
Crossref
Liping Chen, Yaoyao Zhang, Yanru Chen, Ting Wang, Kai Sun, Hao Tang, Wen Shen & Fuhai Ji. (2022) Efficacy and Safety of Botulinum Toxin A and Pulsed Radiofrequency on Postherpetic Neuralgia: A Randomized Clinical Trial. Contrast Media & Molecular Imaging 2022, pages 1-9.
Crossref
Jose-Manuel Quintero, German Pulido, Luis-Fernando Giraldo, Marta-Ximena Leon, Luis-Eduardo Diaz & Rosa-Helena Bustos. (2022) A Systematic Review on Cannabinoids for Neuropathic Pain Administered by Routes Other than Oral or Inhalation. Plants 11:10, pages 1357.
Crossref
Zhiyou Peng, Jianguo Guo, Yanfeng Zhang, Xuejiao Guo, Wenguang Huang, Yunze Li, Zhe Yan, Nannan Guo, Daqiang Ke, Li Chen, Jinyan Huang & Zhiying Feng. (2022) Development of a Model for Predicting the Effectiveness of Pulsed Radiofrequency on Zoster-Associated Pain. Pain and Therapy 11:1, pages 253-267.
Crossref
Xiaochong Fan, Huan Ren, Fuxing Xu, Zhongyuan Lu, Letian Ma, Cunlong Kong, Tao Wang, Huilian Bu & Wenqi Huang. (2022) Comparison of the Efficacy of Short-term Peripheral Nerve Stimulation and Pulsed Radiofrequency for Treating Herpes Zoster Ophthalmicus Neuralgia. The Clinical Journal of Pain 38:11, pages 686-692.
Crossref
Zheng Chen, Niti Shrestha, Chunmei Zhao, Bifa Fan & Fang Luo. (2020) Effect of duloxetine premedication for postherpetic neuralgia within 72 h of herpes zoster reactivation [PROCESS]: a study protocol for a randomized controlled trial. Trials 21:1.
Crossref
Bei Wen, Yajie Wang, Cong Zhang, Weicheng Xu & Zhijian Fu. (2020) Efficacy of different interventions for the treatment of postherpetic neuralgia: a Bayesian network meta-analysis. Journal of International Medical Research 48:12, pages 030006052097741.
Crossref